Christina Wu, MD


Titles and Roles

Associate Professor, Department of Hematology and Medical Oncology
Emory University School of Medicine
Associate Director, Division of Medical Oncology, Department of Hematology and Medical Oncology
Emory University School of Medicine
Medical Oncologist
Colorectal Cancer
Esophageal Cancer
Gastrointestinal Stromal Tumor
Liver Cancer
Neuroendocrine Tumors
Pancreatic Cancer
Stomach Cancer
Phase I Clinical Trials Unit
Research Program
Discovery and Developmental Therapeutics


Christina Wu, MD, is Associate Professor and serves as Associate Division Director of Medical Oncology in the Department of Hematology and Medical Oncology at Emory University School of Medicine. A board certified medical oncologist, Dr. Wu specializes in the treatment of gastrointestinal cancers and is the leader of the colorectal cancer program at Winship Cancer Institute of Emory University. Prior to joining Emory in 2016, Dr. Wu was Assistant Professor in the Division of Medical Oncology in the Department of Internal Medicine at The Ohio State University - James Cancer Hospital and Solove Research Institute. 

Dr. Wu holds professional memberships with American Society of Clinical Oncology, Alliance for Clinical Trials in Oncology, American Association for Cancer Research, and Academic and Community Cancer Research United.


Dr. Wu received her Medical Degree from University of Dublin in Ireland. She completed her residency at University of Massachusetts Memorial Health Center in Worcester, Massachusetts. She completed her fellowship in hematology/oncology at Lombardi Comprehensive Cancer Center in Washington, DC.


Dr. Wu's research involves both translational and clinical studies. She is the co-principal investigator of a phase I clinical trial of trametinib, a MEK inhibitor, in combination with neoadjuvant chemoradiation in rectal cancers that have either KRAS, NRAS, or BRAF mutation, and study champion to NRG-GI002: A Phase II Clinical Trial Platform of Sensitization Utilizing Total Neoadjuvant Therapy (TNT) in Rectal Cancer. Pre-clinical research projects include analyzing colorectal cancer tumors that carry microsatellite instable characteristics and correlating those features with survival and treatment efficacy.

  • Below is a listing of current federal grants for the above principal investigator.



Dr. Wu's articles have been published in a number of leading journals including Cancer, British Journal of Cancer, and Nature Review of Clinical Oncology.

  • PublicationsPublication Date

Additional Websites

Cascade Link   TOP